VYM: A Moderate Growth Fund That Has Some Flaws
Portfolio Pulse from
VYM, a moderate growth ETF, has underperformed the S&P 500 due to lower tech exposure and conservative consumer defensive sector. With a 0.06% expense ratio and 2.61% yield, its core healthcare stocks like Merck and Johnson & Johnson have also underperformed.
February 20, 2025 | 9:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
VYM ETF has underperformed the S&P 500 due to lower exposure to the tech sector and conservative consumer defensive sector. Its core healthcare stocks like Merck and Johnson & Johnson have also underperformed, impacting returns.
VYM's underperformance is attributed to its lower exposure to the high-growth tech sector and reliance on conservative sectors. Additionally, underperformance of key healthcare stocks like Merck and Johnson & Johnson further impacts its returns.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100